Results 71 to 80 of about 6,013 (134)

Effects of Sapropterin on Endothelium-Dependent Vasodilation in Patients With CADASIL: A Randomized Controlled Trial

open access: yes, 2014
BACKGROUND AND PURPOSE: Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a rare autosomal dominant disorder caused by NOTCH3 mutations, is characterized by vascular smooth muscle and endothelial cells
Federico A.   +69 more
core   +2 more sources

Children and Adolescents with Early Treated Phenylketonuria: Cognitive Development and Fluctuations of Blood Phenylalanine Levels

open access: yes
Background: We assessed the relationship between the cognitive development of children and adolescents with phenylketonuria (PKU) and fluctuations in peripheral phenylalanine (Phe) levels.
Josef Weglage   +4 more
core   +1 more source

Determination of sapropterin dihydrochloride in solid dosage froms by visible spectroscopy

open access: yes, 2020
Sapropterin Dihidroklorür, fenilalanin hidroksilaz (PAH) enziminin kofaktörü olan tetrahidrobiyopterin (BH4) 'ün sentetik formudur. Fenilketonüri (PKU) olan kişiler için, oral sapropterin dihidroklorür uygulaması, kandaki fenilalanin seviyesini tirozine dönüştürerek azaltır.
openaire   +1 more source

Effects of commencing sapropterin therapy on quality of life for children with phenylketonuria and their families: a qualitative interview study

open access: yes
Background: Prior to 2018, sapropterin hydrochloride (BH4, Kuvan®) had not been used in Queensland, Australia, to treat sapropterin-responsive phenylketonuria (PKU). This gave our centre at the Queensland Children’s Hospital the opportunity to assess the
Bursle, Carolyn   +10 more
core   +1 more source

Is sapropterin treatment suitable for all subjects with phenylketonuria?

open access: yes, 2008
In a Phase I study, 20% of subjects with phenylketonuria (96/485) responded with a = 30% reduction in blood phenylalanine at day 8 of treatment with sapropterin. Subsequently, some of the responders from this study were enrolled in a Phase III study. The
Sheila Doggrell (20011665)
core  

New drugs: Sapropterin dihydrochloride

open access: yesAustralian Prescriber, 2011
openaire   +1 more source

Use of Special Medical Foods with Sapropterin in PKU

open access: yes, 2019
Background: Phenylketonuria (PKU) is treated with a low phenylalanine (Phe) diet but strict dietary adherence is bur- densome. Sapropterin responsive patients with PKU have an improved Phe tolerance and thereby patients eat more natu- ral protein ...
Yılmaz, Özlem
core  

Lower blood phenylalanine concentrations may be of clinical benefit in adults with phenylketonuria. [PDF]

open access: yesMol Genet Metab Rep
Lubout CMA   +6 more
europepmc   +1 more source

Targeting Mutant Phenylalanine Hydroxylase With Pyrimidine-Triazole Conjugates: A Primary Framework for Candidate Chaperone-Based Strategies in Phenylketonuria. [PDF]

open access: yesFASEB J
Chaturvedi S   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy